Immunovant to present corporate overview at J.P. Morgan Healthcare Conference on Jan 13, 2022

Immunovant, Inc.

CEO Pete Salzmann to present on Thursday, January 13, 2022 at 9:45am ET.
Webcast available via investor relations section of Immunovant's website.
No new financial or clinical data announced in the press release.
Presentation is part of the 40th Annual J.P. Morgan Healthcare Conference (Jan 10-13).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.